Armatus Bio, a late-preclinical stage biotech innovator developing vectorized RNAi medicines in neuromuscular disorders, today announced a new publication in Molecular Therapy Advances summarizing the ...

As gene therapies continue to advance, the demand for scalable, reproducible, and efficient potency assays is rapidly increasing—especially for adeno-associated virus (AAV) vectors. Accurate ...

In vitro assay evaluation is a critical component for T cell engager (TCE) drug discovery, providing essential insights into drug specificity, potency, and mechanism of actions (MOAs). A well-designed ...

Potency assays are essential for product quality and patient safety. These tests enable a direct measurement of a biologic's functional activity, verifying that the therapy works as intended. Potency ...

Amid the coronavirus pandemic, the US Food and Drug Administration has issued guidance on potency assays for manufacturers of monoclonal antibodies and other therapeutic proteins to treat COVID-19.